Companies:
50,331
Total Market Cap:
144518853615936.34
Global Rank
#19806
Country Rank
#1140
Market Cap
224.05 M
Price
22.2
Change (%)
1.77%
Volume
6,615
Beta Drugs Limited's latest marketcap:
224.05 M
As of 08/14/2025, Beta Drugs Limited's market capitalization has reached $224.05 M. According to our data, Beta Drugs Limited is the 19806th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 224.05 M |
| Revenue (ttm) | 41.45 M |
| Net Income (ttm) | 4.85 M |
| Shares Out | 10.09 M |
| EPS (ttm) | 0.48 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/06/2025 |
Market Cap Chart
Data Updated: 08/14/2025
Beta Drugs Limited's yearly market capitalization.
Beta Drugs Limited has seen its market value grow from ₹1.62 B to ₹19.59 B since 2017, representing a total increase of 1,109.25% and an annual compound growth rate (CAGR) of 38.66%.
| Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | ₹19.59 B | $224.05 M | 1.4% | 19806 |
| 12/31/2024 | ₹19.31 B | $225.63 M | 36.67% | 18250 |
| 12/29/2023 | ₹14.13 B | $169.87 M | 107.04% | 19789 |
| 12/30/2022 | ₹6.83 B | $82.46 M | 10.89% | 23542 |
| 12/31/2021 | ₹6.16 B | $82.6 M | 497.76% | 24343 |
| 12/31/2020 | ₹1.03 B | $14.09 M | 56.85% | 30941 |
| 12/27/2019 | ₹656.5 M | $9.2 M | -0.78% | 29136 |
| 12/31/2018 | ₹661.69 M | $9.51 M | -59.15% | 28003 |
| 12/29/2017 | ₹1.62 B | $25.36 M | 24617 |
Company Profile
About Beta Drugs Limited
Beta Drugs Limited is a pharmaceutical company specializing in the development, manufacturing, and sale of anti-cancer drugs in India.
Product Portfolio
- Oncology Products: Focused on treatments for breast, lung, head and neck, colorectal, ovarian, gastric, testicular, renal, and prostate cancers, as well as brain tumors, leukemia, lymphoma, myeloma, and supportive cancer care.
- Dermatology Products: Offers specialized solutions for dermatological conditions.
- Active Pharmaceutical Ingredients (APIs): Engaged in the development of APIs to support drug formulations.
Operations
The company exports its products internationally, expanding its reach beyond the domestic market.
Company Background
Founded in 2005, Beta Drugs Limited is headquartered in Panchkula, India.
Frequently Asked Questions
-
What is Beta Drugs Limited's (NSE-BETA) current market cap?As of 08/14/2025, Beta Drugs Limited (including the parent company, if applicable) has an estimated market capitalization of $224.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Beta Drugs Limited (NSE-BETA) rank globally by market cap?Beta Drugs Limited global market capitalization ranking is approximately 19806 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.